These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 23195779)

  • 1. A phase 2 trial of once-weekly hypofractionated breast irradiation: first report of acute toxicity, feasibility, and patient satisfaction.
    Dragun AE; Quillo AR; Riley EC; Roberts TL; Hunter AM; Rai SN; Callender GG; Jain D; McMasters KM; Spanos WJ
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e123-8. PubMed ID: 23195779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First Results of a Phase 2 Trial of Once-Weekly Hypofractionated Breast Irradiation (WHBI) for Early-Stage Breast Cancer.
    Dragun AE; Ajkay NJ; Riley EC; Roberts TL; Pan J; Rai SN; Jain D; Quillo AR; Scoggins CR; McMasters KM; Woo SY
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):595-602. PubMed ID: 28581400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
    Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
    Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase 2 trial of accelerated, hypofractionated whole-breast irradiation of 39 Gy in 13 fractions followed by a tumor bed boost sequentially delivering 9 Gy in 3 fractions in early-stage breast cancer.
    Kim JY; Jung SY; Lee S; Kang HS; Lee ES; Park IH; Lee KS; Ro J; Lee NK; Shin KH
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1037-42. PubMed ID: 24267970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late toxicity and patient self-assessment of breast appearance/satisfaction on RTOG 0319: a phase 2 trial of 3-dimensional conformal radiation therapy-accelerated partial breast irradiation following lumpectomy for stages I and II breast cancer.
    Chafe S; Moughan J; McCormick B; Wong J; Pass H; Rabinovitch R; Arthur DW; Petersen I; White J; Vicini FA
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):854-9. PubMed ID: 23726000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost.
    Freedman GM; Anderson PR; Goldstein LJ; Ma CM; Li J; Swaby RF; Litwin S; Watkins-Bruner D; Sigurdson ER; Morrow M
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):347-53. PubMed ID: 17379430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary results of electron intraoperative therapy boost and hypofractionated external beam radiotherapy after breast-conserving surgery in premenopausal women.
    Ivaldi GB; Leonardi MC; Orecchia R; Zerini D; Morra A; Galimberti V; Gatti G; Luini A; Veronesi P; Ciocca M; Sangalli C; Fodor C; Veronesi U
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):485-93. PubMed ID: 18407434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute radiation dermatitis and pneumonitis in Japanese breast cancer patients with whole breast hypofractionated radiotherapy compared to conventional radiotherapy.
    Osako T; Oguchi M; Kumada M; Nemoto K; Iwase T; Yamashita T
    Jpn J Clin Oncol; 2008 May; 38(5):334-8. PubMed ID: 18417501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abbreviated course of radiotherapy (RT) for breast cancer.
    Schoenfeld JD; Harris JR
    Breast; 2011 Oct; 20 Suppl 3():S116-27. PubMed ID: 22015277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility and acute toxicity of hypofractionated radiation in large-breasted patients.
    Dorn PL; Corbin KS; Al-Hallaq H; Hasan Y; Chmura SJ
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):79-83. PubMed ID: 22035661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I/II study evaluating early tolerance in breast cancer patients undergoing accelerated partial breast irradiation treated with the mammosite balloon breast brachytherapy catheter using a 2-day dose schedule.
    Wallace M; Martinez A; Mitchell C; Chen PY; Ghilezan M; Benitez P; Brown E; Vicini F
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):531-6. PubMed ID: 19775830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phase 2 Study of 2 Weeks of Adjuvant Whole Breast/Chest Wall and/or Regional Nodal Radiation Therapy for Patients With Breast Cancer.
    Yadav BS; Sharma SC
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):874-881. PubMed ID: 29485066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated hypofractionated whole-breast irradiation with concomitant daily boost in early breast cancer.
    Kyrgias G; Zygogianni A; Theodorou K; Koukourakis M; Oikonomou A; Kouvaris J; Kouloulias V
    Am J Clin Oncol; 2015 Aug; 38(4):358-63. PubMed ID: 23934132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-breast radiotherapy with shorter fractionation schedules following breast-conserving surgery: short-term morbidity and preliminary outcomes.
    Fujii O; Hiratsuka J; Nagase N; Tokiya R; Yoden E; Sonoo H; Murashima N; Iha S; Imajyo Y
    Breast Cancer; 2008; 15(1):86-92. PubMed ID: 18224401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative radiotherapy (IORT) as a boost in patients with early-stage breast cancer -- acute toxicity.
    Kraus-Tiefenbacher U; Bauer L; Kehrer T; Hermann B; Melchert F; Wenz F
    Onkologie; 2006 Mar; 29(3):77-82. PubMed ID: 16514267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of local control and late radiation toxicity after intraoperative radiation therapy boost for early breast cancer.
    Chang DW; te Marvelde L; Chua BH
    Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):73-9. PubMed ID: 24331652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofractionated whole-breast radiation therapy: does breast size matter?
    Hannan R; Thompson RF; Chen Y; Bernstein K; Kabarriti R; Skinner W; Chen CC; Landau E; Miller E; Spierer M; Hong L; Kalnicki S
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):894-901. PubMed ID: 22543209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-Course Hypofractionated Radiation Therapy With Boost in Women With Stages 0 to IIIa Breast Cancer: A Phase 2 Trial.
    Ahlawat S; Haffty BG; Goyal S; Kearney T; Kirstein L; Chen C; Moore DF; Khan AJ
    Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):118-125. PubMed ID: 26700706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Once-Weekly Hypofractionated Whole-Breast Radiotherapy After Breast-Conserving Surgery in Older Patients: A Potential Alternative Treatment Schedule to Daily 3-Week Hypofractionation.
    Rovea P; Fozza A; Franco P; De Colle C; Cannizzaro A; Di Dio A; De Monte F; Rosmino C; Filippi AR; Ragona R; Ricardi U
    Clin Breast Cancer; 2015 Aug; 15(4):270-6. PubMed ID: 25666079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.